We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

104 hedge funds and large institutions have $135M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

24% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 34

9% less funds holding

Funds holding: 114104 (-10)

35% less capital invested

Capital invested by funds: $209M → $135M (-$73.1M)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

95% less call options, than puts

Call options by funds: $24K | Put options by funds: $506K

Holders
104
Holders Change
-10
Holders Change %
-8.77%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
14
Increased
42
Reduced
34
Closed
24
Calls
$24K
Puts
$506K
Net Calls
-$482K
Net Calls Change
+$106K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
26
Rotella Capital Management
Washington
$1.16M +$1.76M +36,692 New
Millennium Management
27
Millennium Management
New York
$1.1M -$2.26M -47,178 -58%
TI
28
Turner Investments
Pennsylvania
$1.03M +$1.56M +32,599 New
GC
29
Globeflex Capital
California
$793K +$1.2M +25,086 +167,240%
BCM
30
Bridgeway Capital Management
Texas
$739K +$981K +20,500 +710%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$721K -$17.7K -371 -2%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$711K +$30.2K +631 +3%
SC
33
Searle & Co
Connecticut
$545K +$825K +17,250 New
Deutsche Bank
34
Deutsche Bank
Germany
$520K -$116K -2,425 -13%
BIM
35
BlackRock Investment Management
Delaware
$495K -$16.9K -353 -2%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$493K -$12.2K -256 -2%
TCIM
37
TIAA CREF Investment Management
New York
$457K +$99.9K +2,088 +17%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$448K +$488K +10,210 +258%
BA
39
BlackRock Advisors
Delaware
$379K +$448K +9,354 +355%
PAM
40
Panagora Asset Management
Massachusetts
$342K -$18.1K -378 -3%
EIM
41
Essex Investment Management
Massachusetts
$266K +$17.7K +371 +5%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$250K -$1.44K -30 -0.4%
SCM
43
Stevens Capital Management
Pennsylvania
$245K +$174K +3,647 +89%
PCM
44
Palisade Capital Management
New Jersey
$231K +$74.2K +1,550 +27%
TA
45
Teachers Advisors
New York
$213K
JAM
46
JW Asset Management
Florida
$212K -$166K -3,466 -34%
UBS Group
47
UBS Group
Switzerland
$205K +$129K +2,700 +71%
PCM
48
Polaris Capital Management
Massachusetts
$180K
CCMH
49
Cornerstone Capital Management Holdings
New York
$177K -$5.74K -120 -2%
ProShare Advisors
50
ProShare Advisors
Maryland
$160K +$58.8K +1,229 +32%

PTX Hedge Fund Activity: Q3 2015 in Review

104 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2015, worth a combined $135M — down 35% from $209M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PTX and 14 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 42 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $23M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $14.8M sold.

  • 104 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2015, down from 114 in Q2 2015.
  • Funds reported $135M of Pernix Therapeutics Holdings, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
  • 14 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2015 and 24 closed out, a net change of -10 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2015 was Armistice Capital, an estimated $23M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2015 was Janus Henderson Investors US, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2015.